investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanisms of Protective Immunity in Ovarian Cancer
Brad Nelson
0 Collaborator(s)
Funding source
Canadian Institutes of Health Research (CIHR)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Brad Nelson
BC Cancer Agency
Vancouver, Canada
Related projects
Linda S Cook
Mitochondrial DNA and Ovarian Cancer Risk and Survival
Ovary
Pathology
Eleftherios P Diamandis
An Integrated Systems Biology Approach for Ovarian Cancer Biomarker Discovery
Ovary
Pathology
Norman Wolmark
NRG Oncology Network Group Operations Center
Ovary
Radiation Oncology
Surgery / Surgical oncology
Charles D Blanke
SWOG Network Group Operations Center of the NCTN
Ovary
Mary Anne Rossing
Epidemiologic Factors and Survival by Molecular Subtypes of Ovarian Cancer
Ovary
Pathology
Kunle O Odunsi
mTOR inhibition for generating memory T cells to enhance ovarian tumor immunity
Ovary
Pathology
Celeste Leigh Pearce
Mechanisms of Prevention of Ovarian Cancer by Oral Contraceptives
Ovary
Pathology
Susan J Ramus
Identifying Prognostic Markers and Therapeutic Targets for Serous Ovarian Cancer
Ovary
Pathology
Igor Jurisica
CRC Tier 1 - Tools and resources for systematically discovering clinically-relevant biomarkers of cancer
Ovary